- Tikosyn
- Dosage: 125-500 mg q12h
- Formulations: C 125, 250, 500
- Comments (Metabolism): May prolong QT interval on EKG and requires initiation in hospital due to potential for torsades de pointes ventricular tachycardia; reduce dose if CrCl is 20-59 mL/min, contraindicated if CrCl <20 mL/min
Notes:
* following a drug name indicates the drug is available as a generic formulation.
BC following a drug name indicates the drug is listed in the 2023 American Geriatrics Society Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.
K = renal elimination; L = hepatic elimination